Budget impact analysis of cenobamate for epilepsy patients with drug-resistant focal onset seizures in the Netherlands.
Saved in:
| Title: | Budget impact analysis of cenobamate for epilepsy patients with drug-resistant focal onset seizures in the Netherlands. |
|---|---|
| Authors: | Li N; Department of Health Services Research, Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, The Netherlands., Majoie M; Department of Research and Development, Epilepsy Center Kempenhaeghe, Heeze, The Netherlands.; Department of Neurosurgery, Maastricht University Medical Center, Maastricht, The Netherlands.; School of Health Professions Education, Faculty of Health, Medicine, and Life Sciences, Maastricht University, Maastricht, The Netherlands.; Academic Center for Epileptology Kempenhaeghe, Maastricht University Medical Center, Maastricht, The Netherlands., Evers S; Department of Health Services Research, Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, The Netherlands.; Center for Economic Evaluation and Machine Learning, Trimbo Institute, Netherlands Institute of Mental Health and Addiction, Utrecht, The Netherlands., Rijkers K; Department of Neurosurgery, Maastricht University Medical Center, Maastricht, The Netherlands.; Academic Center for Epileptology Kempenhaeghe, Maastricht University Medical Center, Maastricht, The Netherlands.; Department of Neurosurgery, Mental Health and Neuroscience Research School, Maastricht University Medical Center, Maastricht, The Netherlands., Gubler F; Department of Neurosurgery, Mental Health and Neuroscience Research School, Maastricht University Medical Center, Maastricht, The Netherlands., Rouhl R; Department of Neurosurgery, Maastricht University Medical Center, Maastricht, The Netherlands.; Academic Center for Epileptology Kempenhaeghe, Maastricht University Medical Center, Maastricht, The Netherlands., Lazeron R; Department of Research and Development, Epilepsy Center Kempenhaeghe, Heeze, The Netherlands., Klarenbeek P; Department of Neurology, Zuyderland Medical Centre, Heerlen, The Netherlands., Laskier-Owens V; FIECON | Health Economics consultancy, Hodgkin Huxley House, London, UK., Hiligsmann M; Department of Health Services Research, Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, The Netherlands. |
| Source: | Journal of medical economics [J Med Econ] 2025 Dec; Vol. 28 (1), pp. 114-123. Date of Electronic Publication: 2025 Jan 02. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: England NLM ID: 9892255 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1941-837X (Electronic) Linking ISSN: 13696998 NLM ISO Abbreviation: J Med Econ Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39686574 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Budget impact analysis of cenobamate for epilepsy patients with drug-resistant focal onset seizures in the Netherlands. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Li+N%22">Li N</searchLink>; Department of Health Services Research, Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Majoie+M%22">Majoie M</searchLink>; Department of Research and Development, Epilepsy Center Kempenhaeghe, Heeze, The Netherlands.; Department of Neurosurgery, Maastricht University Medical Center, Maastricht, The Netherlands.; School of Health Professions Education, Faculty of Health, Medicine, and Life Sciences, Maastricht University, Maastricht, The Netherlands.; Academic Center for Epileptology Kempenhaeghe, Maastricht University Medical Center, Maastricht, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Evers+S%22">Evers S</searchLink>; Department of Health Services Research, Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, The Netherlands.; Center for Economic Evaluation and Machine Learning, Trimbo Institute, Netherlands Institute of Mental Health and Addiction, Utrecht, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Rijkers+K%22">Rijkers K</searchLink>; Department of Neurosurgery, Maastricht University Medical Center, Maastricht, The Netherlands.; Academic Center for Epileptology Kempenhaeghe, Maastricht University Medical Center, Maastricht, The Netherlands.; Department of Neurosurgery, Mental Health and Neuroscience Research School, Maastricht University Medical Center, Maastricht, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Gubler+F%22">Gubler F</searchLink>; Department of Neurosurgery, Mental Health and Neuroscience Research School, Maastricht University Medical Center, Maastricht, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Rouhl+R%22">Rouhl R</searchLink>; Department of Neurosurgery, Maastricht University Medical Center, Maastricht, The Netherlands.; Academic Center for Epileptology Kempenhaeghe, Maastricht University Medical Center, Maastricht, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Lazeron+R%22">Lazeron R</searchLink>; Department of Research and Development, Epilepsy Center Kempenhaeghe, Heeze, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Klarenbeek+P%22">Klarenbeek P</searchLink>; Department of Neurology, Zuyderland Medical Centre, Heerlen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Laskier-Owens+V%22">Laskier-Owens V</searchLink>; FIECON | Health Economics consultancy, Hodgkin Huxley House, London, UK.<br /><searchLink fieldCode="AU" term="%22Hiligsmann+M%22">Hiligsmann M</searchLink>; Department of Health Services Research, Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, The Netherlands. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229892255%22">Journal of medical economics</searchLink> [J Med Econ] 2025 Dec; Vol. 28 (1), pp. 114-123. <i>Date of Electronic Publication: </i>2025 Jan 02. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9892255 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1941-837X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2213696998%22">13696998 </searchLink><i>NLM ISO Abbreviation: </i>J Med Econ <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39686574 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1080/13696998.2024.2443338 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 114 Titles: – TitleFull: Budget impact analysis of cenobamate for epilepsy patients with drug-resistant focal onset seizures in the Netherlands. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Li N – PersonEntity: Name: NameFull: Majoie M – PersonEntity: Name: NameFull: Evers S – PersonEntity: Name: NameFull: Rijkers K – PersonEntity: Name: NameFull: Gubler F – PersonEntity: Name: NameFull: Rouhl R – PersonEntity: Name: NameFull: Lazeron R – PersonEntity: Name: NameFull: Klarenbeek P – PersonEntity: Name: NameFull: Laskier-Owens V – PersonEntity: Name: NameFull: Hiligsmann M IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 12 Text: 2025 Dec Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1941-837X Numbering: – Type: volume Value: 28 – Type: issue Value: 1 Titles: – TitleFull: Journal of medical economics Type: main |
| ResultId | 1 |